Literature DB >> 23210927

Patient-specific whole-body attenuation correction maps from a CT system for conjugate-view-based activity quantification: method development and evaluation.

Katarina Sjögreen Gleisner1, Michael Ljungberg.   

Abstract

For activity quantification based on planar scintillation camera measurements, photon attenuation is an important factor that needs to be corrected for in a patient- and organ-specific manner. One possibility for obtaining attenuation correction maps is to use X-ray CT scout images. Since the intensity of scout images is in relative numbers, their image values need to be multiplied by a factor to become quantitative and thus useful for attenuation correction. The calibration factor can for our current imaging system be obtained from a scanner system file, but is generally not available. For this purpose, a method based on the patient weight has been developed. Results based on 79 patient scout images show that the calibration factor thus determined correlates well with values that, in this case, are independently specified by the system. The accuracy of attenuation correction factors (ACFs) derived from the scout-based attenuation correction maps is evaluated by comparison to ACFs derived from three-dimensional CT studies. For photon energies of 208, 245, and 364 keV, scout-based ACFs are on average 1.2% and 0.5% from the CT-derived values, using the system-based and the weight-based values of the scout-image calibration factor, respectively. The imprecision is somewhat higher for the weight-based method, due to variability in the delineation of the patient contour used as a part of this method. In conclusion, X-ray scouts are found useful for attenuation correction with a satisfactory accuracy obtained, both using the new, weight-based method, and using the previous, system-based method, for determining the required calibration factor.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23210927     DOI: 10.1089/cbr.2011.1082

Source DB:  PubMed          Journal:  Cancer Biother Radiopharm        ISSN: 1084-9785            Impact factor:   3.099


  5 in total

Review 1.  Hybrid Imaging for Patient-Specific Dosimetry in Radionuclide Therapy.

Authors:  Michael Ljungberg; Katarina Sjögreen Gleisner
Journal:  Diagnostics (Basel)       Date:  2015-07-10

Review 2.  Personalized Dosimetry for Radionuclide Therapy Using Molecular Imaging Tools.

Authors:  Michael Ljungberg; Katarina Sjögreen Gleisner
Journal:  Biomedicines       Date:  2016-11-15

3.  Feasibility of simplifying renal dosimetry in 177Lu peptide receptor radionuclide therapy.

Authors:  Anna Sundlöv; Johan Gustafsson; Gustav Brolin; Nadja Mortensen; Rebecca Hermann; Peter Bernhardt; Johanna Svensson; Michael Ljungberg; Jan Tennvall; Katarina Sjögreen Gleisner
Journal:  EJNMMI Phys       Date:  2018-07-05

4.  Modelling of energy-dependent spectral resolution for SPECT Monte Carlo simulations using SIMIND.

Authors:  Michaella Morphis; Johan A van Staden; Hanlie du Raan; Michael Ljungberg
Journal:  Heliyon       Date:  2021-02-10

5.  EANM dosimetry committee recommendations for dosimetry of 177Lu-labelled somatostatin-receptor- and PSMA-targeting ligands.

Authors:  Katarina Sjögreen Gleisner; Nicolas Chouin; Pablo Minguez Gabina; Francesco Cicone; Silvano Gnesin; Caroline Stokke; Mark Konijnenberg; Marta Cremonesi; Frederik A Verburg; Peter Bernhardt; Uta Eberlein; Jonathan Gear
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-03-14       Impact factor: 10.057

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.